Pregnant women with hepatitis c get new hope from antiviral drug
NCT ID NCT05140941
First seen Feb 04, 2026 · Last updated May 12, 2026 · Updated 12 times
Summary
This study is testing a 12-week course of the hepatitis C drug Sofosbuvir/Velpatasvir in about 100 pregnant women. The goal is to see if the treatment cures the infection and whether it affects the timing of delivery. Mothers are followed for 12 weeks after treatment, and babies are monitored for one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Marshall University
Huntington, West Virginia, 25755, United States
-
The Christ Hospital
Cincinnati, Ohio, 45219, United States
-
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
Toronto General Hospital, University Health Network
Toronto, Ontario, M5G 2C4, Canada
-
University Health Toronto, St Michaels Hospital
Toronto, Ontario, M5B 1W8, Canada
-
University of Pittsburgh, Magee Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Victoria Hospital, London Health Sciences Center
London, Ontario, N6A 5W9, Canada
Conditions
Explore the condition pages connected to this study.